Cerulea Clinical Trials

Clinical Trials

Study of a Suprachoroidal Retinal Prosthesis

This study follows on from an initial proof of concept study and will test a second-generation retinal prosthesis device, which can be used outside of the laboratory environment (i.e. is fully implantable). This study is operated by the Centre for Eye Research Australia.

Overview

This study follows on from an initial proof of concept study (n=3) between 2012 and 2014, and will test a second-generation retinal prosthesis device, which can be used outside of the laboratory environment (i.e. is fully implantable).

The primary outcome measure is safety of the surgical implantation assessed by the number and severity of serious adverse events compared to other retinal prosthesis.

The secondary outcome measure is the efficacy, ability of the device to generate a visual response and measures of visual function and functional vision.

  • Principal Investigator
Assocaite Professor Penelope Allen

Learn more

View this study at ClinicalTrials.gov

This international database listing provides more detailed information about this study.